|
Name |
2,2-Dimethyl-2H-chromene-6-carboxylic acid
|
Molecular Formula | C12H12O3 | |
IUPAC Name* |
2,2-dimethylchromene-6-carboxylic acid
|
|
SMILES |
CC1(C=CC2=C(O1)C=CC(=C2)C(=O)O)C
|
|
InChI |
InChI=1S/C12H12O3/c1-12(2)6-5-8-7-9(11(13)14)3-4-10(8)15-12/h3-7H,1-2H3,(H,13,14)
|
|
InChIKey |
AXICIBPYBONRSP-UHFFFAOYSA-N
|
|
Synonyms |
2,2-Dimethyl-2H-chromene-6-carboxylic acid; 34818-56-9; Anofinic acid; 2,2-dimethylchromene-6-carboxylic acid; CHEMBL469159; C12H12O3; 2H-1-Benzopyran-6-carboxylic acid, 2,2-dimethyl-; 2,2-dimethyl-2H-1-benzopyran-6-carboxylic acid; 6-Carboxy-2,2-dimethylchromen; SCHEMBL8066269; DTXSID10415747; CHEBI:172317; 1-Hydroxy-3',3'-dimethylchromene; BDBM50499720; MFCD06208181; ZINC15119467; AKOS016028545; SS-3624; 2,2-Dimethyl-6-chromenecarboxylic acid; 2,2-Dimethyl-2H-chromene-6-carboxylicacid; CS-0358926; 2,2-Dimethyl-2H-benzo[b]pyran-6-carboxylic Acid
|
|
CAS | 34818-56-9 | |
PubChem CID | 5319235 | |
ChEMBL ID | CHEMBL469159 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 204.22 | ALogp: | 2.8 |
HBD: | 1 | HBA: | 3 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 46.5 | Aromatic Rings: | 2 |
Heavy Atoms: | 15 | QED Weighted: | 0.763 |
Caco-2 Permeability: | -4.657 | MDCK Permeability: | 0.00002700 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.009 | 20% Bioavailability (F20%): | 0.035 |
30% Bioavailability (F30%): | 0.39 |
Blood-Brain-Barrier Penetration (BBB): | 0.337 | Plasma Protein Binding (PPB): | 91.48% |
Volume Distribution (VD): | 0.373 | Fu: | 5.40% |
CYP1A2-inhibitor: | 0.084 | CYP1A2-substrate: | 0.304 |
CYP2C19-inhibitor: | 0.042 | CYP2C19-substrate: | 0.06 |
CYP2C9-inhibitor: | 0.14 | CYP2C9-substrate: | 0.207 |
CYP2D6-inhibitor: | 0.185 | CYP2D6-substrate: | 0.154 |
CYP3A4-inhibitor: | 0.066 | CYP3A4-substrate: | 0.141 |
Clearance (CL): | 2.704 | Half-life (T1/2): | 0.847 |
hERG Blockers: | 0.027 | Human Hepatotoxicity (H-HT): | 0.796 |
Drug-inuced Liver Injury (DILI): | 0.922 | AMES Toxicity: | 0.005 |
Rat Oral Acute Toxicity: | 0.922 | Maximum Recommended Daily Dose: | 0.068 |
Skin Sensitization: | 0.286 | Carcinogencity: | 0.524 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.83 |
Respiratory Toxicity: | 0.922 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004350 | 0.431 | D0N0RU | 0.291 | ||||
ENC005711 | 0.417 | D0C4YC | 0.273 | ||||
ENC005619 | 0.406 | D01WJL | 0.273 | ||||
ENC003153 | 0.400 | D06NVJ | 0.269 | ||||
ENC005626 | 0.397 | D0L7FM | 0.260 | ||||
ENC003405 | 0.381 | D07HBX | 0.259 | ||||
ENC004186 | 0.381 | D0DJ1B | 0.257 | ||||
ENC004187 | 0.381 | D09BHB | 0.257 | ||||
ENC005620 | 0.380 | D05FTJ | 0.247 | ||||
ENC000296 | 0.377 | D07BPS | 0.247 |